Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Current Perspectives on Selective Dopamine D3 Receptor Antagonists/Partial Agonists as Pharmacotherapeutics for Opioid and Psychostimulant Use Disorders
Amy Hauck Newman, Zheng‐Xiong Xi, Christian Heidbreder
Current topics in behavioral neurosciences (2022), pp. 157-201
Open Access | Times Cited: 21

Showing 21 citing articles:

The chronic unpredictable mild stress (CUMS) Paradigm: Bridging the gap in depression research from bench to bedside
Shweta Sharma, Shivani Chawla, Praveen Kumar, et al.
Brain Research (2024) Vol. 1843, pp. 149123-149123
Closed Access | Times Cited: 8
The dopamine 3 receptor as a candidate biomarker and therapeutic for opioid use disorder
Matthew L. Banks, Jon E. Sprague
Addiction Biology (2024) Vol. 29, Iss. 2
Open Access | Times Cited: 3
A highly D3R-selective and efficacious partial agonist (S)-ABS01-113 compared to its D3R-selective antagonist enantiomer (R)-ABS01-113 as potential treatments for opioid use disorder
Ewa Galaj, Guo‐Hua Bi, Benjamin Klein, et al.
Neuropsychopharmacology (2022) Vol. 47, Iss. 13, pp. 2309-2318
Open Access | Times Cited: 17
Effects of selective dopamine D3 receptor partial agonist/antagonists on oxycodone self-administration and antinociception in monkeys
Kendall Woodlief, Mia I Allen, Jeremy C. Cornelissen, et al.
Neuropsychopharmacology (2023) Vol. 48, Iss. 12, pp. 1716-1723
Closed Access | Times Cited: 9
Pharmacological and Physicochemical Properties Optimization for Dual-Target Dopamine D3 (D3R) and μ-Opioid (MOR) Receptor Ligands as Potentially Safer Analgesics
Alessandro Bonifazi, Elizabeth Saab, Julie Sanchez, et al.
Journal of Medicinal Chemistry (2023) Vol. 66, Iss. 15, pp. 10304-10341
Open Access | Times Cited: 8
AM6527, a neutral CB1 receptor antagonist, suppresses opioid taking and seeking, as well as cocaine seeking in rodents without aversive effects
Omar Soler-Cedeño, Hannah Alton, Guo‐Hua Bi, et al.
Neuropsychopharmacology (2024) Vol. 49, Iss. 11, pp. 1678-1688
Open Access | Times Cited: 2
Arrestin-3 Agonism at Dopamine D3 Receptors Defines a Subclass of Second-Generation Antipsychotics That Promotes Drug Tolerance
Selin Schamiloglu, Elinor Lewis, Caroline M. Keeshen, et al.
Biological Psychiatry (2023) Vol. 94, Iss. 7, pp. 531-542
Open Access | Times Cited: 7
Presynaptic and Postsynaptic Mesolimbic Dopamine D3 Receptors Play Distinct Roles in Cocaine Versus Opioid Reward in Mice
Zheng‐Xiong Xi, Miriam E Bocarsly, Ewa Galaj, et al.
Biological Psychiatry (2024) Vol. 96, Iss. 9, pp. 752-765
Closed Access | Times Cited: 1
Involvement of dopamine D3 receptor in impulsive choice decision-making in male rats
Hui Shen, Zilu Ma, Emma Hans, et al.
Neuropharmacology (2024) Vol. 257, pp. 110051-110051
Closed Access | Times Cited: 1
Altered Accumbal Dopamine Terminal Dynamics Following Chronic Heroin Self-Administration
Brianna George, Monica H. Dawes, Emily G. Peck, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 15, pp. 8106-8106
Open Access | Times Cited: 8
Dopamine D3/D2 Receptor Ligands Based on Cariprazine for the Treatment of Psychostimulant Use Disorders That May Be Dual Diagnosed with Affective Disorders
Emma Gogarnoiu, Caleb D. Vogt, Julie Sanchez, et al.
Journal of Medicinal Chemistry (2023) Vol. 66, Iss. 3, pp. 1809-1834
Open Access | Times Cited: 4
Are There Prevalent Sex Differences in Psychostimulant Use Disorder? A Focus on the Potential Therapeutic Efficacy of Atypical Dopamine Uptake Inhibitors
Melinda Hersey, Mattingly K. Bartole, Claire S. Jones, et al.
Molecules (2023) Vol. 28, Iss. 13, pp. 5270-5270
Open Access | Times Cited: 3
A mechanistic overview of approaches for the treatment of psychostimulant dependence
Kathrine L. Jensen, Søren Brøgger Jensen, Kenneth L. Madsen
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 5
Design and Synthesis of Conformationally Flexible Scaffold as Bitopic Ligands for Potent D3-Selective Antagonists
Ho Young Kim, Ji Youn Lee, Chia‐Ju Hsieh, et al.
International Journal of Molecular Sciences (2022) Vol. 24, Iss. 1, pp. 432-432
Open Access | Times Cited: 5
The selective D3-Receptor antagonist VK4-116 effectively treats behavioral inflexibility in rats caused by self-administration and withdrawal from cocaine
Marios C. Panayi, S S Shetty, Micaela Porod, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 2
The selective D3Receptor antagonist VK4-116 reverses loss of insight caused by self-administration of cocaine in rats
Marios C. Panayi, S S Shetty, Micaela Porod, et al.
Neuropsychopharmacology (2024) Vol. 49, Iss. 10, pp. 1590-1599
Open Access
Natural Product-Inspired Dopamine Receptor Ligands
Michael Dorogan, Namballa Hari Krishna, Wayne W. Harding
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 15, pp. 12463-12484
Open Access
Substance- and Cell-Specific Roles of Mesolimbic Dopamine D3 Receptors
Freja Herborg
Biological Psychiatry (2024) Vol. 96, Iss. 9, pp. 691-693
Closed Access
Selective dopamine D3 receptor partial agonist (±)VK4-40 reduces the reinforcing strength of d-amphetamine but not cocaine in rhesus monkeys responding under a progressive-ratio schedule of reinforcement
Mia I Allen, Evan Lewis, Jianjing Cao, et al.
Drug and Alcohol Dependence (2024) Vol. 265, pp. 112494-112494
Closed Access
Association of dopamine D2-like and D3 receptor function with initial sensitivity to cocaine reinforcement in male rhesus monkeys
Paul W. Czoty, Aaron M. Tryhus, Kiran Kumar Solingapuram Sai, et al.
Brain Research (2023) Vol. 1807, pp. 148323-148323
Open Access | Times Cited: 1
Fluoroalkoxylated C-3 and C-9 (S)-12-bromostepholidine analogues with D1R antagonist activity
Namballa Hari Krishna, Ann M. Decker, Michael Dorogan, et al.
Bioorganic Chemistry (2023) Vol. 141, pp. 106862-106862
Open Access | Times Cited: 1
Page 1

Scroll to top